Heparin Drug Development

NewsGuard 100/100 Score

Heparin is a naturally occurring anticoagulant. Heparin is contained in mast cells and is released into blood vessels at sites of tissue injury to prevent blood clots forming.

Heparin and several heparin derivatives such as enoxapain, dalteparin and tinzaparin are used to prevent patients at high risk of pulmonary embolism and deep vein thrombosis. The drug has also been used in the treatment of several other conditions and some of these are described below.

  • Heparin has been tested in controlled clinical trials as a treatment for adult respiratory distress syndrome (ARDS). Suggested mechanisms include reduction in the activation and accumulation of cells in airways and neutralization of mediators and toxins from cells. Animal models have shown that heparin improves lung function.
  • Heparin is being tested in controlled trials as a treatment for asthma after animal models suggested the drug could improve lung function.
  • The clinical benefit of heparin in the treatment of allergic rhinitis is being tested in controlled clinical trials.
  • Animal studies are being conducted to explore the effects of heparin as a treatment for allergic encephalomyelitis.
  • Molecular studies suggest that heparin may have beneficial effects as an arthritis treatment, by preventing cell accumulation and collagen destruction.
  • Animal models also suggest that heparin may have anticancer effects through prevention of tumor growth, angiogenesis and cancer spread.
  • Controlled clinical trials have suggested potential benefits in the treatment of inflammatory bowel disease.
  • In animal models, heparin prolongs survival after allografts procedures have been performed.

Further Reading

Last Updated: Jun 20, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, June 20). Heparin Drug Development. News-Medical. Retrieved on May 30, 2024 from https://www.news-medical.net/health/Heparin-Drug-Development.aspx.

  • MLA

    Mandal, Ananya. "Heparin Drug Development". News-Medical. 30 May 2024. <https://www.news-medical.net/health/Heparin-Drug-Development.aspx>.

  • Chicago

    Mandal, Ananya. "Heparin Drug Development". News-Medical. https://www.news-medical.net/health/Heparin-Drug-Development.aspx. (accessed May 30, 2024).

  • Harvard

    Mandal, Ananya. 2023. Heparin Drug Development. News-Medical, viewed 30 May 2024, https://www.news-medical.net/health/Heparin-Drug-Development.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study detects biomarker changes nearly 30 years before symptom onset of Alzheimer’s disease